Celebrating 6 months at @VCSpecialists by learning from each other about the latest data/future directions in breast + lung cancer. Fortunate to know and work with them. Not pictured are the wonderful Dr. Anne Favret and Dr. Shruti Tiwari!
Congratulations to all of our fellows completing their training at MD Anderson. We look forward to seeing all that you accomplish in your careers and are grateful for your dedication to #EndCancer.
First oral presentation at #NANETS2022 for this clinician! So much still to learn about the molecular differences between G3 NETs + NECs and potential for transformation. π¦π§¬
I interviewed Puerto Ricoβs health secretary who stressed to me how the U.S. gives much less money to Puerto Rico than it does to even the U.S.V.I, & other states, when it comes to Medicare funding. He brought in Luis Pizarro to further explain. He did an excellent job. Watch.
Cure for a rare and severe blood disorder should not depend on a oneβs ability to cover 6 months of living expenses for themselves and their caregiver required for a stem cell transplant. Please consider supporting @IgrylCH patient in his fight for cure. https://t.co/EqRDDmD3K2
Just yesterday I was discussing legacy projects with a patient facing terminal illness. This beautiful piece reminds me just how impactful these can be- a forever gift.ππ
"Her words, written to bridge the gap between us, cut through space and time." https://t.co/KaAw6GqV9n
@esinghimd @AndrewJallouk@GuoJin1@MadhuEluri 7/Dr. @IgrylCH presented the results from this retrospective analysis analyzing the outcomes of patients with melanoma with elevated LDH treated with first line targeted therapy or immune checkpoint inhibition ππ π https://t.co/4iX0cwP3Oa
π¨ The March 2021 edition of MDA Fellows JCWatch is now available. Scroll ππ½ to read through all 5οΈβ£ exciting #journalclub summaries. This month, we cover studies in #crcsm#hematology#bcsm!
#hemeonc#meded